Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Art Optical Contact Lens specializes in the design, manufacture, and distribution of custom contact lenses—including rigid gas permeable (GP), scleral, multifocal/presbyopic, orthokeratology/myopia control ("MOONLENS"), toric/astigmatic, pediatric, post-surgical/irregular cornea designs. Their products are FDA-cleared medical devices used by eyecare professionals to manage a wide range of refractive errors and ocular surface diseases. The company has introduced several proprietary technologies to improve fit precision and patient comfort. No clinical trial results apply as these are regulated as Class II medical devices with established safety/effectiveness profiles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Art Optical Contact Lens.